Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01831817 · ClinicalTrials.gov registry record · Phase 2
Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity
A Phase 2 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
NCT01831817 is a Phase 2 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 140 participants.
The verdict
NCT01831817, a Phase 2 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
Study Summary
The purpose of this exploratory study is to compare the treatment effect on dentinal hypersensitivity of a tubule occluding dentifrice as measured by Schiff and Tactile sensitivity. This proof of concept study will compare the test dentifrice with three other treatment groups.
Interventions
- DRUG Sodium monofluorophosphate dentifrice
- DRUG 5% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice
- DRUG 0% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice
- DRUG Sodium Fluoride dentifrice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01831817
The ClinicalTrials.gov registry entry for NCT01831817 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Sodium monofluorophosphate dentifrice is the first listed.
NCT01831817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01831817 about?
NCT01831817 is a clinical study titled "Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity". The purpose of this exploratory study is to compare the treatment effect on dentinal hypersensitivity of a tubule occluding dentifrice as measured by Schiff and Tactile sensitivity. This proof of concept study will compare the test dentifrice with three other treatment groups.
What is the current status of trial NCT01831817?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2013-01. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01831817?
The interventions under investigation include: Sodium monofluorophosphate dentifrice (DRUG), 5% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice (DRUG), 0% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice (DRUG), Sodium Fluoride dentifrice (DRUG).
Who is sponsoring clinical trial NCT01831817?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.